摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide | 63424-42-0

中文名称
——
中文别名
——
英文名称
N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide
英文别名
N-[5-nitro-2-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]hexadecanamide
N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide化学式
CAS
63424-42-0
化学式
C28H46N2O9
mdl
——
分子量
554.7
InChiKey
VQANZNCUHNPTGV-FWZZJMFBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    39
  • 可旋转键数:
    18
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    174
  • 氢给体数:
    5
  • 氢受体数:
    9

文献信息

  • PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE BETA-GALACTOSIDASE (RHGALC)
    申请人:Ace Biosciences A/S
    公开号:EP2920198A1
    公开(公告)日:2015-09-23
  • PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE B-GALACTOSIDASE (rhGALC)
    申请人:ACE BIOSCIENCES A/S
    公开号:US20150284698A1
    公开(公告)日:2015-10-08
    The present invention relates to a process for purifying recombinant human Galactocerebroside β-Galactosidase dase (rhGALC) from a cell culture, wherein a fraction of said cell culture comprising rhGALC is subjected to chromatography on three distinct resins.
  • [EN] TREATING PROTEIN MISFOLDING DISEASES<br/>[FR] TRAITEMENT DES PATHOLOGIES DE MAUVAIS REPLIEMENT DES PROTÉINES
    申请人:MAYO FOUNDATION
    公开号:WO2009061906A2
    公开(公告)日:2009-05-14
    This document provides methods and materials related to treating a protein misfolding disease. For example, methods and materials relating to the use of a lobeline compound to treat a protein misfolding disease are provided.
  • [EN] PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE &bgr;-GALACTOSIDASE (rhGALC)<br/>[FR] PURIFICATION DE GALACTOCÉREBROSIDE &Bgr;-GALACTOSIDASE HUMAINE RECOMBINANTE (RHGALC)
    申请人:ACE BIOSCIENCES AS
    公开号:WO2014075688A1
    公开(公告)日:2014-05-22
    The present invention relates to a process for purifying recombinant human Galactocerebroside β-Galactosidase (rhGALC) from a cell culture, wherein a fraction of said cell culture comprising rhGALC is subjected to chromatography on three distinct resins.
查看更多